March Biosciences
Houston, US · Founded 2021 · Delaware corporation · 8 known investors
March Bioscience is a cell therapy company assembling leading scientists and drug developers to advance cell therapy treatments. The company focuses on developing therapeutics in the cell and gene therapy space.
Founders & leadership
March Biosciences was founded in 2021 by Sarah Hein, Maksim Mamonkin, and Malcolm Brenner.
SH
Sarah HeininCEO, Co-Founder
MM
Maksim MamonkinCo-Founder, Chair Scientific Advisory Board
MB
Malcolm BrennerCo-founder
Board
Investors · 8
Reported raises · per SEC filings
Form D private placements$22.1M disclosed across 2 rounds · 2023–2024
▶$22.1MraisedOct 2024 · 22 investors · BiotechnologyRule 506(b)
▶$22.1MraisedOct 2024 · 22 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Thomas LubyDirector
- Peter OlagunjuDirector
- Joseph PetrosinoDirector
- Sarah HeinDirector, Executive Officer
- Maksim MamonkinDirector, Executive Officer
- Offering amount
- $22.1M
- Amount sold
- $22.1M
- First sale
- Oct 2024
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$8.9KraisedSep 2023 · 1 investors · BiotechnologyRule 506(b)
▶$8.9KraisedSep 2023 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Sarah HeinExecutive Officer, Director
- Offering amount
- $8.9K
- Amount sold
- $8.9K
- Minimum investment
- $8.9K
- First sale
- Sep 2023
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 4
by search overlapbio11 shared keywordsThe Biotechnology Innovation Organization (BIO) is an advocacy organization representing biotech companies, industry leaders, and state biotech associations across the United States and more than 35 countries. It provides members with policy advocacy, cost-saving programs, educational webinars, and organizes the BIO International Convention and other industry conferences.
Solid Biosciences10 shared keywordsSolid Biosciences is a precision genetic medicine company developing a pipeline of gene therapy candidates for rare neuromuscular and cardiac diseases, including Duchenne muscular dystrophy, Friedreich's ataxia, CPVT, and TNNT2-mediated dilated cardiomyopathy. It also develops genetic regulator libraries and delivery platform technologies intended to improve gene therapy delivery.
Mammoth Biosciences10 shared keywordsMammoth Bio develops technology to read and write the code of life, operating in the biotechnology sector.
Mission BioCapital Platinum Program Holdings LLC9 shared keywordsMission BioCapital is an early-stage venture capital firm that provides capital and shared lab space to life science startups, supporting founders from initial experiments through to the clinic. Founded in 2009, it invests in early-stage life science companies and is currently deploying its fifth fund.
Companies competing with March Biosciences for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does March Biosciences do?
- March Bioscience is a cell therapy company assembling leading scientists and drug developers to advance cell therapy treatments. The company focuses on developing therapeutics in the cell and gene therapy space.
- Who founded March Biosciences?
- March Biosciences was founded by Sarah Hein, Maksim Mamonkin, Malcolm Brenner in 2021.
- Who are March Biosciences's investors?
- March Biosciences's investors include Mission Biocapital, 4BIO Capital, Cancer Fund, Fitz Gate Ventures, Modi Ventures, Portal Innovations, TMC Venture Fund, KdT Ventures.
- How much funding has March Biosciences raised?
- March Biosciences has disclosed $22.1M raised across 2 rounds.
- Where is March Biosciences headquartered?
- March Biosciences is headquartered in Houston, US.